Market data not licensed for redistribution.
DongKoo Bio & Pharma – 5% holder report
006620 · KOSDAQ · Filed 2026-10-29 KST · 주식등의대량보유상황보고서(일반)
The key numbers, in plain words 5% holder report
- 조용준 holds 37.18% of the company.
- Full report: the holder may want a say in management, or holds for general investment.
- Anyone holding 5% or more must report each change of 1 point or more.
From the filing and DART structured data. Facts only, not advice; the Korean original prevails.
History for this filing type
After 34,015 similar filings (Insider / major-holder ownership report), the stock did better than the market the next day 46% of the time (avg -0.0% vs. the market). Past results, not a prediction. Reaction stats
All key numbers (as filed)
| holder ko | 조용준 |
| pct | 37.18 |
| pct change | 0 |
| shares | 10,604,678 |
| shares change | 0 |
| report type | general |
| reason ko | 담보 대출 일부 상환에 따른 변경 보고 |
Korean original on DART: DART 20261029000548
For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer → Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
© Crypvu · Crypto market view
Market data not licensed for redistribution.
© Crypvu · Crypto market view